HHS seeks to protect drugmakers from anti-kickback laws ahead of TrumpRx launch
With launch time potentially approaching for TrumpRx, HHS unveiled part of its plan to shield drugmakers from anti-kickback laws to allow them to sell their products on the new direct-to-consumer platform.
The guidance — released via ...
⚠️ 风险分析 中
摘要：美国HHS计划为药企提供反回扣法豁免，以支持TrumpRx直销平台。
影响：若政策落地，可能改变美国药品直销规则，影响在美销售的中国药企或跨境医药电商的合规策略。
建议：关注美国HHS最终政策细节，评估对现有药品销售合规框架的潜在冲击。
「素履以往」
Not the sharpest mind, but the steadiest hand.
Not the sharpest mind, but the steadiest hand.